Stevanato Group S.p.A. (STVN) News
Latest headlines that mention STVN, newest first · each headline opens the original publisher
- Last price
- $19.47
- Day change
- -3.80%
- Next earnings
- 2026-11-03 BMO
STVN headlines
latest coverageRevenue grew 8% as high-value solutions surged 16%, driving adjusted EBITDA up 21%.
Italian healthcare vials and cartridges maker Stevanato Group and U.S. generic and wholesale pharmaceutical company Cencora are two of the best healthcare buys right now.
Image source: The Motley Fool. Thursday, May 7, 2026 at 8:30 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading
STVN news alerts
Get an alert by email or push when a new headline mentions STVN.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.